– Sales of $20.7 billion reflecting strong growth of 3.3%, operational growth of 4.8%* and adjusted operational growth of 5.6%*, inclusive of the overall estimated negative impact of the COVID-19 pandemic – EPS of $2.17 increased 56.1%; adjusted EPS of $ 2.30 increased 9.5%* – Dividend increase of 6.3% announced […]
Financial
DiNovA Medtech Announces Vivek Y. Reddy, MD to Join as Portfolio Company’s Medical Advisor and Cofounder
HANGZHOU, China, April 14, 2020 /PRNewswire/ — DiNovA Medtech, the leading medical devices incubator in China (“DiNovA”, or the “Company”), is pleased to announce Vivek Y. Reddy, MD to join as Chief Medical Advisor and Cofounder of portfolio company Nuomao Medtech (“Nuomao”) to lead cardiac arrhythmia related innovations. Vivek Y. Reddy, MD is the Director […]
Blackstone and Alnylam Enter Into $2 Billion Strategic Financing Collaboration to Accelerate the Advancement of RNAi Therapeutics
– RNAi Represents One of the Most Promising and Rapidly Advancing Frontiers in Biology and Drug Development Today with Potential to Transform Lives of Patients – – Blackstone Provides a Customized Investment at Scale to Enable Alnylam to Achieve Self-sustainable Financial Profile Without Need for Future Equity Financing – – […]
Itamar™ Medical Announces First Quarter 2020 Preliminary Revenue Increase of Approximately 40%
– Company Ramping Up WatchPAT™ ONE Production Capacity to Meet Demand for Disposable Home Sleep Apnea Tests – CAESAREA, Israel, April 13, 2020 (GLOBE NEWSWIRE) — Itamar Medical Ltd. (Nasdaq: ITMR) (TASE: ITMR), a medical technology company focused on the development and commercialization of non-invasive medical devices, solutions and a […]
Correvio Obtains Interim Order For Plan Of Arrangement
NASDAQ: CORV TSX: CORV VANCOUVER, April 8, 2020 /PRNewswire/ – Correvio Pharma Corp. (“Correvio” or the “Company“) (NASDAQ: CORV) (TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital drugs, today announced that it has obtained an interim order from the Supreme Court of British Columbia (the “Court“) authorizing the holding of an annual general and special meeting […]
AtriCure Announces Preliminary Financial Results for First Quarter 2020 and Provides COVID-19 Pandemic Update
MASON, Ohio–(BUSINESS WIRE)–AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced preliminary financial results for the first quarter 2020 and provided updates in response to the COVID-19 pandemic. “Through these challenging times, our first priority continues to be the […]
Zynex Announces 126% Order Growth and Increases Q1 and Full-Year Revenue Estimates
ENGLEWOOD, Colo., April 7, 2020 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced orders and an increased revenue estimate for Q1 and the full year 2020. Orders in the first quarter […]
BioTelemetry, Inc. Names Dr. Andrei Stoica Chief Technology Officer
MALVERN, Pa., April 07, 2020 (GLOBE NEWSWIRE) — BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today that Dr. Andrei Stoica has been named Chief Technology Officer of the company. Dr. […]
McDermott + Bull Places Vice President of Clinical Affairs, Adagio Medical, Inc.
by Tori Leets | Apr 6, 2020 | Ken Dropiewski, Placement Announcement McDermott + Bull has successfully placed Richard Van Bibber as the Vice President of Clinical Affairs at Adagio Medical, Inc. He will be charged with overseeing and managing the company’s sponsored global pre-market and post-market clinical studies and is currently driving the enrollment and […]
Endologix Announces Preliminary Financial Results for First Quarter 2020
IRVINE, Calif.–(BUSINESS WIRE)–Endologix, Inc. (the “Company”) (NASDAQ: ELGX), a developer and marketer of innovative treatments for aortic disorders, today announced that its preliminary unaudited revenue for the first quarter ended March 31, 2020 is expected to be approximately $28.5 million. Total cash, cash equivalents, and restricted cash as of March […]



